Requests similar to 'Meeting notes and outcomes' (page 3)
OFI patient numbers & Costs
Response by Pharmaceutical Management Agency to Jennifer Jiayi on .
Partially successful.
Kia ora Jennifer
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac...
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear R Whyte
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
16 April 2018
Via Email: [e...
Comirnaty: Redaction of adverse events in the Medsafe safety data sheet
Request sent to Ministry of Health by Erika Whittome on .
Long overdue.
The minutes for the "COVID-19 Vaccine Technical Advisory Group meetings" minutes dated Feb and Mar 2021 state that :
-all the trials have limited...
Extent to which strategy policy & legislation Deputy Director General Maree Roberts briefed - metabolic syndrome, mental health & ultraprocessed food
Response by Ministry of Health to J Bruning on .
Partially successful.
Kia ora
Please find attached a response to your request for information, reference
H2023033842.
Please accept our apologies for the confusion with r...
Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine
Response by Pharmaceutical Management Agency to John Armstrong on .
Partially successful.
Kia ora John
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
____...
MoH Public Health Agency Deputy Director-General – Is Dr Andrew Old briefed/driving policy on metabolic syndrome, mental health & ultraprocessed food & nutritional deficiency
Response by Ministry of Health to J Bruning on .
Partially successful.
Kia ora
Please find attached a letter regarding your request for information
Ngā mihi
OIA Services Team
Manatū Hauora | Minis...
Fluoride Supply Chain Information
Response by Ministry of Health to Sovereign sharna on .
Awaiting classification.
Kia ora Sovereign Sharna,
Thank you for your LGOIMA request initially sent to the Ministry of
Health, who confirmed with you the partial tra...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Your request has been transferred from the Ministry of Health to Pharmac
for response. Our reference number for your request is 202...
Pfizer of Medsafe Criminal Referral
Follow up sent to New Zealand Police by Chuck Schooner (Account suspended) on .
Refused.
This was the response I was expecting and not surprising. When they sign off this vaccine for children in January which they will inevitably do you...
DSS and NASC Access for People with Long Covid, and Myalgic Encephalomyelitis
Response by Ministry for Disabled People to Scout Barbour-Evans on .
Awaiting classification.
This email is confidential and may contain information that is subject to
legal privilege. If it is not intended for you please do not read,
dist...
Oestradiol (Estradot) patches, Oestradiol gel and other products
Response by Pharmaceutical Management Agency to M Williams on .
Partially successful.
Kia ora,
Please find a response to your Official Information Act request attached.
Thank you
Government Services - Pharmac
5 June 2024
M Williams
V...
Rationale for defunding of Androderm 2.5mg Patches
Response by Pharmaceutical Management Agency to Scout Barbour-Evans on .
Successful.
Hello Scout
Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018.
In October 2016, the manufacturers proposed del...
Cost of spending on Caresens Diabetes test kits
Request sent to Pharmaceutical Management Agency by Harry Peterson on .
Long overdue.
What is the annual cost spent by Pharmac on diabetes finger pricking kits, testing strips and needles?
Yours faithfully,
Harry Peterson
Informed Consent #17 - New list of adverse events
Request sent to Ministry of Health by Annie Weston on .
Refused.
According to Pfizer's recently released analysis the below is a list of the adverse events of special interest that could occur after taking their v...
The reasons as per s3.2 of Justice Committee minutes dated 12 August 2021 for not taking further action on petition 87688
Request sent to Office of the Clerk of the House of Representatives by John Creser on .
Waiting clarification.
Thank you for your email today in respect of my earlier request to your office. I will mark off your response as answered on this site in respect of...
Management of Stelazine (trifluoperazine) supply
Response by Pharmaceutical Management Agency to WGRH on .
Information not held.
Dear Dr Harrison,
Please find PHARMAC's response to your OIA request attached.
Please let me know if you have any questions on this.
Kind Regards,...
Suspicious Medicine Usage
Response by Ministry of Health to David Robinson on .
Awaiting classification.
Kia ora David
Please find attached a response to your request for official information.
Ngā mihi,
Government Services | Pharmac
___...
All the information collected and disseminated by the Justice Select Committee in petition 87688
Response by Office of the Clerk of the House of Representatives to John Creser on .
Long overdue.
Dear Mr Creser
Attached are the minutes of the Justice Committee meeting and Justice subcommittee meeting at which your petition was considered. Infor...
Referral of request to Standing Orders Committee
Request to Office of the Clerk of the House of Representatives by John Creser. Annotated by John Creser on .
Partially successful.
RE: Official Information request - Request for the report of petition 87688 dated 1 April 2021 and 12August 2021
The following response from David Wi...
Kia ora A Mark
Please find attached a response to your request for information regarding
funding decisions for Trikafta.
Ngā mihi
...
Pandemic Vaccine Procurement, India FTA Implications, and Advance Purchase Agreement Framework
Request sent to Pharmaceutical Management Agency by Penny Claridge on .
Awaiting response.
Pursuant to the Official Information Act 1982, I request the following information:
All internal briefing papers, policy documents, legal opinions...
Maori Advisory Committee
Response by Pharmaceutical Management Agency to Alan Riley on .
Successful.
Kia ora Alan,
Please find attached a response to your Official Information Act request,
which was received on 13 November 2024.
Please con...
Management of Dexamfetamine supply
Response by Pharmaceutical Management Agency to Anita Easton on .
Partially successful.
Dear Anita
Please find attached PHARMAC’s response to your recent OIA request.
Kind regards
Victoria London
PHARMAC
15 March 2016...
MoH Clinical, Community and Mental Health Deputy Director-General – Is Robyn Shearer briefed/driving policy on the relationship of poor mental health with ultraprocessed food & nutritional deficiency
Response by Ministry of Health to J Bruning on .
Successful.
Kia ora
Thank you for your four requests under the Official Information Act
received by Mantū Hauora (the Ministry of Health) on 8 December 2023...
MoH Evidence Research and Innovation Deputy Director-General – Is Dean Rutherford briefed/driving policy on metabolic syndrome, mental health & ultraprocessed food & nutritional deficiency
Response by Ministry of Health to J Bruning on .
Partially successful.
Kia ora
Thank you for your four requests under the Official Information Act
received by Mantū Hauora (the Ministry of Health) on 8 December 2023...